Anshul Thakral

Anshul Thakral is Chief Executive Officer of Fortrea (Nasdaq: FTRE), having joined the company in August 2025. He also serves as a member of Fortrea’s Board of Directors.

Experts highlight how CRO-site partnerships advance phase III CV trials

Leveraging expedited programs in oncology: How accelerated approval helps drug developers get cancer drugs to patients faster

Fortrea's Alaric Jackson Talks AI in Clinical Trials

Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy

Optimize your product development journey and drive innovation with insightful guidance from our experienced global team

Flexible FSP resourcing meets evolving needs for an oncology biotech